Thus, high total IGF-I levels in CKD is inadequate in suppressing the increased GH levels because of the lower IGF-I bioactivity resulting in the lack of IGF-I feedback on pituitary GH secretion (75, 77) (Table 1; Figure 3). This evidence concerns the gene GH1 and chronic kidney disease.